Stock Movers Intel Rallies, Eli Lilly Jumps, Paccar Soars
Sep 26, 2025
Intel's shares surge as a potential new US chip policy aims to lessen reliance on overseas production. The company may partner with Apple and TSMC to jumpstart its manufacturing capabilities. Eli Lilly sees a boost with proposed 100% tariffs on patented drugs, positioning itself favorably against international competitors. Meanwhile, Paccar's stock skyrockets due to a new 25% tariff on heavy trucks imported from abroad, benefiting domestic manufacturers as overseas peers struggle.
AI Snips
Chapters
Transcript
Episode notes
Intel Benefits From Potential Chip Import Limits
- The Wall Street Journal reports the Trump administration may limit chip imports with a one-for-one domestic production rule.
- Intel is benefiting as it has U.S. foundries and is exploring partnerships with TSMC and Apple to boost manufacturing and investment.
Tariff Shock Could Favor U.S. Drug Makers
- President Trump announced a 100% tariff on patented drug imports with exemptions for U.S. manufacturing construction.
- Markets see Eli Lilly as a potential winner because it has more U.S. manufacturing compared with peers like Novo Nordisk.
Furniture Tariffs Hurt Import-Dependent Retailers
- A 30% tariff on imported upholstered furniture hit import-dependent retailers hard.
- Wayfair, Restoration Hardware and Williams-Sonoma all fell as markets priced in higher costs and supply-chain disruption.